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Background/Aims: Microscopic colitis (MC) encompasses 
collagenous and lymphocytic colitis and is characterized 
by chronic diarrhea. In cases of MC, colonic mucosae are 
macroscopically normal, and diagnostic histopathological 
features are observed only upon microscopic examination. 
We designed a prospective multicenter study to determine 
the clinical features, pathological distribution in the colon 
and prevalence of MC in Korea. Methods: We prospectively 
enrolled patients having watery diarrhea no more than 3 
times a day between March 2008 and February 2009. We 
obtained patient histories and performed colonoscopies with 
random biopsies at each colon segment. Results: A total of 
100 patients with chronic diarrhea were enrolled for a nor-
mal colonoscopy and stool exam. MC was observed in 22 pa-
tients (22%) (M:F 1.2:1; mean age, 47.5 years). Of those 22 
patients, 18 had lymphocytic colitis and 4 had collagenous 
colitis. The entire colon was affected in only 3 cases (13.6%), 
the ascending colon in 6 cases (27.2%), the transverse colon 
in 3 cases (13.6%), and the left colon in 3 cases (13.6%). 
More than 2 segments were affected in 7 cases (31.8%). 
Nonsteroidal anti-inflammatory drug-associated MCs were 
observed in 4 cases (18.2%), 3 of which showed improved 
diarrhea symptoms following discontinuation of the medica-
tion. Frequently associated symptoms were abdominal pain 
and weight loss. Autoimmune diseases were observed in 
4 cases (18.2%). Half of the 22 patients with MC improved 
with conservative care by loperamide or probiotics. Conclu-
sions: In a prospective multicenter study of Korean patients 
with chronic diarrhea, the frequency of MC was found to 
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be approximately 20%, similar to the percentage observed 
in Western countries. Therefore, the identification of MC is 
important for the adequate management of Korean patients 
with chronic diarrhea. (Gut Liver 2011;5:181-186)
Key Words: Chronic diarrhea; Microscopic colitis; Collag-
enous colitis; Lymphocytic colitis
INTRODUCTION
The main symptom of microscopic colitis is chronic watery 
diarrhea. Despite the grossly normal mucosa, it displays typical 
histol    ogic abnormalities. Microscopic colitis is classified as col-
lagenous co    litis, in which subepithelial     collagen layer thickens 
around 10 to 100 μm and lymphocytic colitis,     characterized by 
the presence of a lymphocytes more than 20 in 100 epithelial 
cells.
1
In Western countries, it has become apparent that microscop-
ic colitis is a common cause of diarrhea, particularly in middle-
aged or elderly patients.
2 Its etiology and pathophysiology 
has not been proven yet, but it seems to associate with using 
of various medication such as lansoprazole and non-steroidal 
anti inflammatory drugs (NSAIDs).
3,4 Also many reports shows 
microscopic colitis is associated with celiac disease and autoim-
mune diseases, such as Type I diabetes and thyroid disease.
2 
There has been a rapid increase in researches and publica-
tions on this disease entity. In Korea, interest about microscopic 
colitis has been increasing, and some clinical reports by single 
center are available. Therefore, Korean Association for the Study 
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of the Intestinal Disease (KASID) designed of research on fre-
quency of microscopic colitis and clinical pattern of the patient 
with chronic diarrhea in Korea through the prospective multi-
center study. 
MATERIALS AND METHODS
1. Subjects
It was a manifold collaboration research from March 2008 to 
February 2009 with the adults over 15 years old with chronic 
diarrhea. Chronic diarrhea is defined as watery diarrhea more 
than 3 times a day at least for 4 weeks. However, those cases 
showing inflammation in colonic mucosa such as inflammatory 
bowel disease and abnormal stool exam showing steatorrhea 
and parasite infection were excluded in the research. 
2. Methods
Two mucosal biopsies were taken from every segment of the 
colon (cecum, ascending colon, transverse colon, descending 
colon, and sigmoid colon) and from the rectum. The histologi-
cal features of microscopic colitis are chronic inflammatory 
cells infiltrating the lamina propria of mucosa, increase of in-
traepithelial lymphocyte (IEL) and epithelial damage, such as 
flattening and detachment. The number of IEL is more than 20 
in 100 epithelial cells in lymphocytic colitis (LC) (Fig. 1A). The 
thickness of subepithelial collagen layer is more than 10 μm in 
collagenous colitis (CC) (Fig. 1B and C). Also we divided into 
two subgrouped, if the case shows the number of lymphocyte is 
10 to 20 in 100 epithelial cells diagnosed as suspicious LC and 
the thickness of the collagen layer is 5 to 10 μm diagnosed as 
suspicious CC. 
3. Statistical analysis
Independent t-test was used for ages, the number of diar-
rhea and the period between microscopic colitis (MC) group 
Fig. 1. Pathologic finding of microscopic colitis. (A) Lymphocytic 
colitis (H&E stain, ×400). Note the intraepithelial lymphocytosis and 
mixed inflammatory infiltrate in the lamina propria, as well as the 
surface epithelial damage. In distinction from ulcerative colitis or 
Crohn’s colitis, the crypt architecture is normal. (B) Collagenous colitis 
(H&E stain, ×200). (C) Collagenous colitis (Masson’s trichrome stain, 
×400). In addition to the inflammatory infiltrate, note the thickened 
subepithelial collagen band.
Fig. 2. Diagnostic rate of microscopic colitis. 
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and normal tissue group. For the comparisons of MC group and 
suspicious MC group and normal tissue, one-way ANOVA was 
used. Chi-square test was used for relation between drugs and 
autoimmune disease, and for statistics, SPSS 12.0 program (SPSS 
Inc., Chicago, IL, USA) was used. 
RESULTS
1. Clinical characteristics of patients
We enrolled 100 patients with chronic diarrhea, 58 males and 
42 females, who show normal colonoscopic finding. The mean 
age was 45 years old. Twenty-two patients were diagnosed as 
microscopic colitis (22%), 10 were females and mean age was 
44.9±18.0 years. Seven patients were diagnosed with suspicious 
microscopic colitis (7%). There were 18 cases of lymphocytic 
colitis, 4 cases of collagenous colitis, 4 of suspicious LC and 3 
of suspicious CC (Fig. 2). There was no significant difference 
among MC group, suspicious MC group and normal tissue 
group in clinical characteristics. All three groups varied in the 
number of diarrhea and the period of having diarrhea (Table 1). 
While patients with microscopic colitis with lymphocytic colitis 
were in their 20s, patients with collagenous colitis were in their 
70s (Fig. 3).
2. Distribution of microscopic colitis 
Followings are the pathological lesions of 22 patients: 6 cases 
in the ascending colon (30%), 3 in the transverse colon (15%), 3 
in the descending colon and the rectum (15%). Only 3 showed 
diffuse distribution throughout the colon (15%), and more than 
two segments of the colon were involved in 5 patients (15%) 
(Table 2).
3. Drug related microscopic colitis
From 100 days prior to the development of diarrhea, we took 
drug history including NSAIDs, proton pump inhibitor (PPI), 
lipid lowering agents, aspirin and other anticoagulants for more 
than 2 weeks. The relation between each medicine and micro-
scopic colitis was not statistically significant. However, 7 of the 
22 patients with microscopic colitis (32%) showed suspicious 
drug consumption. Taking NSAIDs was in 4 cases (18.2%), one 
case taking aspirin and clopidogrel and another case taking 
aspirin, simvastatin, and NSAIDs. NSAIDs were related with 2 
patients with collagenous colitis and 2 lymphocytic colitis. Two 
patients with collagenous colitis improved diarrhea a month 
after discontinuing the suspicious NSAIDs as well as aspirin and 
clopidogrel. 
4. Relation to autoimmune disease
Among 22 patients with microscopic colitis, 4 patients (18.2%) 
presented autoimmune disease: 2 thyroid disease, 1 type 1 dia-
betes, and 1 idiopathic hypereosinophilic syndrome. There is 
significant correlation between microscopic colitis and autoim-
Fig. 3. Age distribution of microscopic coltis. 
LC, lymphocytic colitis; CC, collagenous colitis.
Table 1. Clinical Characteristics of the Enrolled Patients
Feature
Normal pathology
(n=71)
Suspicious LC 
(n=4)
Suspicious CC 
(n=3)
LC
(n=18)
CC
(n=4)
Mean age, yr   44.3±17.8   51±14.1 44.67±13.3 43.17±19.0 67.0±9.6
M:F 1.45:1 1:1 2:1 2:1 0:4
Duration, wk   46.0±79.5 131.0±246.0 121.33±155.2   150.7±232.0   16.5±22.4
Frequency 4.60±2.4 6.3±2.6     3.3±0.58   4.1±2.5   5.3±1.9
LC, lymphocytic colitis; CC, collagenous colitis.
Table 2. Distribution of Involved Colonic Segments of Microscopic 
Colitis
Distribution LC (n=18)  CC (n=4)
Ascending colon 5 (27.8) 1 (25.0)
Transverse colon 2 (11.1) 1 (25.0)
Descending, sigmoid colon, rectum 3 (16.7) 0
Entire colon 1 (5.5) 2 (50.0)
More than 2 segments 7 (38.9) 0
Data are presented as number (%).
LC, lymphocytic colitis; CC, collagenous colitis.184  Gut and Liver, Vol. 5, No. 2, June 2011
mune disease (p<0.05).
5. Relation to irritable bowel syndrome
There was only one patient showing symptoms of irritable 
bowel syndrome (ROME III) of 22 patients diagnosed as micro-
scopic colitis. 
6. Treatment of microscopic colitis
The improvement of diarrhea after probiotics shown in 4 
cases (18.2%), loperamide was medicated in 8 cases (36.4%), 
budesonide was in one case (4.5%), mesalazine was in one case 
(4.5%). Other 3 cases show relief after quitting suspicious drug 
and there were 5 cases were following by conservative treat-
ment.
DISCUSSION
Chronic diarrhea is a common symptom in the division of 
gastroenterology and, microscopic colitis may be one of the im-
portant causes of chronic diarrhea.
5
The terminology, microscopic colitis, first mentioned in the 
case of a patient with chronic diarrhea whose colon shows 
no visible abnormality but infiltration in lymphocyte on tis-
sue biopsy in 1980.
6 Collagenous colitis was first described by 
Lindström
5 in 1976 and lymphocytic colitis by Lazenby et al.
6 in 
1989.
In Western countries, the incidence rate of collagenous colitis 
is 0.6-2.3/100,000, while the prevalence rate is 10-15.7/100,000. 
The incidence rate of lymphocytic colitis is 3.1/100,000, while 
the prevalence rate is 14.4/100,000.
7,8 According to the cur-
rent report from Olesen et al.,
2 in Western, an incidence rate of 
collagenous colitis increases from 3.7/100,000 to 6.1/100,000, 
and that of lymphocytic colitis increase from 3.1/100,000 to 
5.7/100,000 every year. In Western countries, the male to fe-
male ratio is 1:3 in collagenous colitis and 1:2.5 in lymphocytic 
colitis. The average age is 63.8 for female and 60.7 for male.
9 
There are no available data in Korea and Asia about the inci-
dence and prevalence of microscopic colitis. However, previous 
single center study on 2008 reported that the domestic frequen-
cy was 15%.
8 According to this multicenter study, the diagnostic 
frequency of microscopic colitis among chronic diarrhea is 22%. 
It means that microscopic colitis is not a rare disease entity any 
more and shows increasing frequency in Korea as well as in 
Western countries. This study also shows that there is difference 
in sex ratio and average age in Korea compared to Western. 
Especially, lymphocytic colitis was diagnosed among much 
younger patient, 20s-40s, compared to previous research.
1,2,5,7-9 It 
could mean that the young patients with chronic diarrhea might 
have been misdiagnosed as irritable bowel syndrome without 
tissue biopsy.
10 
The cause of microscopic colitis is not yet clear, bile acids, 
toxin, infection,
11-13 and especially drugs such as NSAIDs, H2 
blocker, PPI
14 seems to play an important role in microscopic 
colitis. These factors increase bowel permeability and cause an 
influx of antigens into lamina propria. And then theses induce 
inflammation, epithelial cell may be involved in immune system 
additionally.
15,16 This hypothesis is supported to, in contrast to 
when exposed to fecal materials, not reaction of inflammation 
when it was not exposed to fecal materials such as ileostomy. 
But we could not find accumulation of immune complex, com-
plement, immunoglobulin.
Microscopic colitis patients presented with autoimmune dis-
ease such as thyroid disease, type I diabetes and rheumatic ar-
thritis and its rate is 40% to 50%.
17 There is a higher prevalence 
rate of hypercholesterolemia and thyroid disease among patient 
with microscopic colitis.
9 From this study, 18.2% of patient 
showed an association with autoimmune disease (p<0.05). How-
ever, its correlation with each of the autoimmune disease has 
not been proved so far.
Collagenous colitis occurring group take NSAIDs 5 times 
more than the control group, and taking NSAIDs worsens the 
diarrhea and stopping them relieves the symptom. It is sug-
gested that NSAIDs caused the inflammation during the initia-
tive phase of the disease.
18,19 Two cases of collagenous colitis 
patient taking NSAIDs in this study also resolved diarrhea after 
discontinuing the drug. It was reported that other drugs also 
may cause microscopic colitis. Aacarbose, aspirin, lansoprazole, 
ranitidine, sertraline, and ticlopidine have higher chance of 
causing the disease. Also, carbamazepine, flutamide, lisinopril, 
levodopa, benserazide, oxetorone, paroxetine, simvastatin, tar-
dyferon, vinburnine are categorized as the causing drugs.
3,4 
There is a theory that bacterial infection is one of the causes 
of microscopic colitis, based on the facts that biopsy specimen 
of microscopic colitis shows concomitant acute inflammation, 
collagenous colitis like a pathology after C. difficile
20 or Y. en-
terocolitica
21 infection and relieve of symptom after antibiotics 
treatment in some patient, but the suspicious bacteria is not 
found yet. 
Also, an increase of nitric oxide production by inducible ni-
tric oxide synthase (iNOS) in colonic epithelium of microscopic 
colitis patient was observed and budesonide decreases iNOS 
mRNA, which shows clinical and histological improvement.
1
The cause of collagen deposit in collagenous colitis is not 
known yet. Basement membrane of epithelium in normal colon 
is composed of type III collagen and produced by fibroblast 
between crypts of colon mucosa, then it moves to superior por-
tion of the organ along with the crypts and develop 5 to 7 μm 
of collagen layer in subepithelium. However, the collagen layer 
consists of type I, III and VI and thickens from 7 to 80 μm in 
collagenous colitis. A decrease of sodium absorption in lympho-
cytic colitis and a increase of chloride secretion in collagenous 
colitis induce diarrhea as a common symptom in both disease.
22 
Microscopic colitis has a significant relation with irritable 
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the standard criteria of IBS (ROMEIII), the Western study reports 
the 28% match and claims that colonoscopy with histology 
confirm is important in patients suspicious irritable bowel syn-
drome.
23
The distribution of microscopic colitis is not even. In some 
case of collagenous colitis, thickening of subepithelial collagen 
layer distributes on ascending and transverse colon, it does not 
appear in the sigmoid colon and rectum.
24 Also in lymphocytic 
colitis, some of lesion spread in ascending and transverse colon, 
therefore sigmoidoscopy is not enough to diagnose the micro-
scopic colitis. Nine cases out of 22 cases (40.9%) of microscopic 
colitis in this study are diagnosed in ascending and transverse 
colon. 
A group of patients with suspicious lymphocytic colitis and 
suspicious collagenous colitis in this study, who show increase 
in intraepithelial lymphocytes or thickening of collagen layer 
which doesn’t fit the definition, is still to be concerned about 
whether the condition will progress or not. There is no report on 
this, but it should be followed up with concern.
As far as the treatment of microscopic colitis is concerned, 
patients should avoid caffeine and alcohol which worsen the 
symptom. The drug therapy should be accompanied with the 
diet modification. The principle of treatment is step up therapy. 
When symptom is mild, loperamide and cholestyramine can be 
administrated, if there is no reaction to these drugs, budesonide, 
and aminosalicilates can be used. Also, when resistance to ste-
roid occurs, immunosuppressive drugs, such as azathioprine and 
methotraxate, can be administrated. It has been suggested that 
budesonide, 9 mg/day for 6 to 8 weeks, is the most effective.
25 
However, the limitation of budesonide is that when treatment 
is stopped, the symptom is recurrent. Therefore there is further 
research to find the right period of treatment.
1 The symptoms 
were controlled by stopping causing drugs, and budesonide and 
mesalazine were added for one case and the treatment result is 
being observed. 
Long term prognosis of microscopic colitis is favorable in 
general. One study reported that in the case of collagenous coli-
tis, 63% was resolved for 3.5 years and only 29% of the case 
needed continuing drug therapy.
15 In the case of lymphocytic 
colitis, more than 80% cases show improvement in clinical 
symptoms and histology for 38 months. There are reports of 
malignancy in the cases of collagenous colitis with breast can-
cer (2.34%), lung cancer (1.75%), and colorectal cancer (2.82%). 
In the case of lymphocytic colitis, there were patients with 
breast cancer (5.31%), lung cancer (1.06%), and prostate cancer 
(1.86%).
2 However, there were no statistically significant rela-
tion yet between microscopic colitis and malignancy including 
colorectal cancer. Therefore, it will be necessary to keep moni-
toring the 22 patients diagnosed with microscopic colitis in this 
study.
There has been an increase of the patients with chronic diar-
rhea diagnosed as microscopic colitis. This study tries to know 
the frequency, clinical characteristics, causing factor and treat-
ment result of microscopic colitis in Korea through multicenter 
prospective study. Although the frequency might have been 
higher than the actual case since the enrolled patient were treat-
ed in teaching hospital or institutional hospital, it suggests that 
the frequency of microscopic colitis in Korea is about the same 
level in Western countries. Further nation-wide study on the 
incidence and epidemiology, pathophysiology, and treatment of 
microscopic colitis will be expected in the future. 
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